Giant Cell Arteritis

Showing 1-2 of 2 giant cell arteritis:

Does OM1 have a polymyalgia rheumatica (PMR) dataset similar to the PremiOM GCA dataset?

July 24, 2023

OM1 does not currently offer a PremiOM PMR dataset; however, consistent with the established epidemiology of the conditions, almost half of the GCA patients in the PremiOM dataset have concomitant PMR. If a broader set of PMR patients is required, a custom cohort of PMR patients (with and without concomitant GCA) can be licensed separately.

We would like to define treatment patterns for GCA patients with tocilizumab or glucocorticoids. For glucocorticoids, we need dose and days of supply information in order to track dose changes (tapering) over time. The medication dose/days of supply information can be inconsistent from my previous experience with EMR and open claims? Can you share if OM1 has used a tapering algorithm in published studies?

July 24, 2023

Our research team has not used a tapering algorithm to look at dose over time.To calculate dose for oral medications at single points in time, the team uses quantity dispensed divided by days supply multiplied by strength. Note, the Steroid Dose calculated in the dataset is an average daily dose suitable for oral and injectable[…]